Guidelines for the safe production and quality control of inactivated poliomyelitis vaccine manufactured from wild polioviruses (Addendum, 2003, to the Recommendations for the Production and Quality Control of Poliomyelitis Vaccine (Inactivated)
WHO collaborative study to establish a replacement International Standard for anti-poliovirus sera, Expert Committee on Biological Standardization, Geneva, 22-29 October 1991
Report of a collaborative study to assess the suitability of a replacement International Standard for Oral Polio Vaccine, Expert Committee on Biological Standardization, Geneva, 15-19 November 2004
Proposal to establish an International Standard for MAPREC analysis of poliovirus type 3 (Sabin)
Expert Committee on Biological Standardization, Geneva, 7-11 October 1996
WHO Collaborating Centers on Standardization on Regulatory Evaluation of Vaccines & Biotherapeutic Products: 1st meeting, Geneva, 24-26 April 2012
WHO Workshop on implementing WHO Guidelines on evaluating similar biotherapeutic products (SBPs), Xiamen, China, 28-30 May 2012
WHO Informal Consultation on the revision of the recommendations to assure the Quality, Safety and Efficacy of biological products prepared by recombinant DNA technology, Xiamen, China, 31 May-1 June 2012
CONTACTS
Quality, Safety and Standards (QSS)
Immunization, Vaccines and Biologicals (IVB)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971
